1-1 of 1
Kimberly Rice
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MC210807: Phase 1 clinical trial assessing the safety and efficacy of onvansertib, a novel, oral, PLK1 inhibitor in Relapsed/Refractory myeloproliferative chronic myelomonocytic leukemia (CMML).

Free
Abhishek Mangaonkar, Kristen McCullough, Susan Geyer, Ashya Burgess, Kimberly Rice, Eric Asmus, Patricia Koenig, Terra Lasho, Christy Finke, Rachel Reither, Ryan Carr, Jenna Fernandez, Antoine Saliba, Aref Al-Kali, Martin Fernandez-Zapico, Mrinal Patnaik
Journal: Blood
Blood (2025) 146 (Supplement 1): 5634.
https://doi.org/10.1182/blood-2025-5634
Published: 2025